CLINICAL_TRIALS
trial_result
· 2025-05-02
Clinical Trial Update: Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder [Phase 3]
Summary
A Phase 3 trial evaluating lumateperone as adjunctive therapy for major depressive disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2025-05-02